Research Publications

Cameron RB. STAT3, Cten, and lung cancer: Simultaneous excitement and caution.  J Thorac Cardiovasc Surg.  2015;149(1):376-7.

Kotova S, Wong RM, Cameron, RB.  New and emerging therapeutic options for malignant pleural mesothelioma:  review of early clinical trials.  Cancer Mannagement and Research. 2015;7:1-12.

Olevsky O, Wong RM, Cameron RB.  New results and concepts in Systemic Treatment of Mesothelioma.  Proceedings of UCLA Healthcare.  2014;18.

Burt BM, Cameron RB, Mollberg NM, Kosinski AS, Schipper PH, Shrager JB,Vigneswaran WT.  Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.  J ThoracCardiovasc Surg.  2014;148(1):30-5.

Wong RM, Ianculescu I, Sharma S, Gage DL, Olevsky OM, Kotova S, Kostic MN,Grundfest WS, Hou D, Cameron RB.  Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.  Am J Respir Cell Mol Biol.  2014;50(5):870-5.

Cameron RB, Hou D.  Intraoperative hyperthermic chemotherapy perfusion formalignant pleural mesothelioma: an in vitro evaluation.  J Thorac Cardiovasc Surg.  2013;145(2):496-504.
Srivastava MK, Zhu L, Harris-White M, Huang M, St John M, Lee JM, Salgia R,Cameron RB, Strieter R, Dubinett S, Sharma S.  Targeting myeloid-derivedsuppressor cells augments antitumor activity against lung cancer. Immunotargets Ther.  2012;2012(1):7-12.

Kachroo P, Pak PS, Sandha HS, Lee C, Elashoff D, Nelson SD, Chmielowski B,Selch MT, Cameron RB, Holmes EC, Eilber FC, Lee JM.  Single-institution,multidisciplinary experience with surgical resection of primary chest wallsarcomas.  J Thorac Oncol.  2012;7(3):552-8.

Kachroo P, Pak PS, Sandha HS, Nelson SD, Seeger LL, Cameron RB, Eilber FC, Lee JM.  Chest wall sarcomas are accurately diagnosed by image-guided core needle biopsy.  J Thorac Oncol.  2012;7(1):151-6.

Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP,Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D.  Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res.  2011;4(7):984-93.

Gielda BT, Peng R, Coleman JL, Thomas CR, Cameron RB.  Treatment of early stage thymic tumors: surgery and radiation therapy.  Curr Treat Options Oncol. 2008;9(4-6):259-68.

Carballo M, Maish MS, Jaroszewski DE, Yetasook A, Bauer K, Cameron RB, Carmack Holmes E.  Video-assisted thoracic surgery (VATS) for resection of metastatic adenocarcinoma as an acceptable alternative.  Surg Endosc.  2009;23(9):1947-54.

Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN, Kloss R, MaxfieldRA, Munawar MI, Pass HI, Rashid A, Rom WN, Schmitt P, Wai J.  Detection of lung cancer using weighted digital analysis of breath biomarkers.  Clin Chim Acta.  2008;393(2):76-84.

Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN, Greenberg J, KlossR, Maxfield RA, Munawar MI, Pass HI, Rashid A, Rom WN, Schmitt P.  Prediction of lung cancer using volatile biomarkers in breath.  Cancer Biomark.  2007;3(2):95-109.

Dohadwala M, Yang SC, Luo J, Sharma S, Batra RK, Huang M, Lin Y, Goodglick L, Krysan K, Fishbein MC, Hong L, Lai C, Cameron RB, Gemmill RM, Drabkin HA,Dubinett SM.  Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.  Cancer Res.  2006;66(10):5338-45.

Beseth BD, Cameron RB, Leland P, You L, Varricchio F, Kreitman RJ, Maki RA,Jablons DM, Husain SR, Puri RK.  Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts.  Ann Thorac Surg.  2004;78(2):436-43;

Lee TT, Everett DL, Shu HK, Jahan TM, Roach M 3rd, Speight JL, Cameron RB, Phillips TL, Chan A, Jablons DM.  Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.  J Thorac Cardiovasc Surg. 2002;124(6):1183-9.